Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Theo Tritton, Catherine Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J Rothnie, Felix JF Herth, Jennifer K Quint & Afisi S Ismaila. (2023) Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2039-2054.
Read now
Read now
David Price, Rupert Jones, Pascal Pfister, Hui Cao, Victoria Carter, Anu Kemppinen, Björn Holzhauer, Alan Kaplan, Allan Clark, David M G Halpin, Hilary Pinnock, James D Chalmers, Job F M van Boven, Kai M Beeh, Konstantinos Kostikas, Nicolas Roche, Omar Usmani & Paul Mastoridis. (2021) Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes. Pragmatic and Observational Research 12, pages 25-35.
Read now
Read now
Ian D Pavord, Kenneth R Chapman, Mona Bafadhel, Frank C Sciurba, Eric S Bradford, Stephanie Schweiker Harris, Bhabita Mayer, David B Rubin, Steven W Yancey & Pierluigi Paggiaro. (2021) Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1755-1770.
Read now
Read now
Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2018) Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 12:8, pages 693-708.
Read now
Read now
Gaetano Caramori, Paolo Ruggeri, Paolo Casolari, Kian Fan Chung, Giuseppe Girbino & Ian M. Adcock. (2017) Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 11:12, pages 955-967.
Read now
Read now
Mario Cazzola, Paola Rogliani, Luigino Calzetta, Nicola A. Hanania & Maria Gabriella Matera. (2017) Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 552-563.
Read now
Read now
Dave Singh, Massimo Corradi, Monica Spinola, Alberto Papi, Omar S Usmani, Mario Scuri, Stefano Petruzzelli & Jørgen Vestbo. (2017) Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2917-2928.
Read now
Read now
M. H. Roberts, M. E. Borrego, A. A. Kharat, P. L. Marshik & D. W. Mapel. (2016) Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 167-192.
Read now
Read now
D van Ranst, WA Stoop, JW Meijer, HJ Otten & IG van de Port. (2014) Reduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation program. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 1059-1067.
Read now
Read now
Muhammad Ahsan Zafar, Christopher Droege, Madeline Foertsch & Ralph J Panos. (2014) Update on ultra-long-acting β agonists in chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs 23:12, pages 1687-1701.
Read now
Read now
Articles from other publishers (17)
Tmirah Haselkorn, Stanley J. Szefler, Bradley E. Chipps, Eugene R. Bleecker, Michelle S. Harkins, Brandee Paknis, Farid Kianifard, Benjamin Ortiz & Robert S. Zeiger. (2020) Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR II. The Journal of Allergy and Clinical Immunology: In Practice 8:7, pages 2243-2253.
Crossref
Crossref
Alan J. Gray, Molly HustonDevin DidericksenTanya K. MeyerAlbert MeratiSimon Brisebois. (2019) The minimal clinically important difference of the dyspnea index in laryngotracheal stenosis. The Laryngoscope 130:7, pages 1775-1779.
Crossref
Crossref
Marloes Dankers, Marjorie H. J. M. G. Nelissen-Vrancken, Sara M. K. Surminski, Anke C. Lambooij, Tjard R. Schermer & Liset van Dijk. (2020) Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Hanan Aboumatar, Mohammad Naqibuddin, Suna Chung, Hina Chaudhry, Samuel W. Kim, Jamia Saunders, Lee Bone, Ayse P. Gurses, Amy Knowlton, Peter Pronovost, Nirupama Putcha, Cynthia Rand, Debra Roter, Carol Sylvester, Carol Thompson, Jennifer L. Wolff, Judith Hibbard & Robert A. Wise. (2019) Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease. JAMA 322:14, pages 1371.
Crossref
Crossref
Usman Maqsood, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Ran Wang, Iain Crossingham & David JW Evans. (2019) Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019:3.
Crossref
Crossref
Alberto Papi, Jinping Zheng, Gerard J. Criner, Leonardo M. Fabbri & Peter M.A. Calverley. (2019) Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study. Respiratory Medicine 147, pages 37-43.
Crossref
Crossref
Hanan Aboumatar, Mohammad Naqibuddin, Suna Chung, Hina Chaudhry, Samuel W. Kim, Jamia Saunders, Lee Bone, Ayse P. Gurses, Amy Knowlton, Peter Pronovost, Nirupama Putcha, Cynthia Rand, Debra Roter, Carol Sylvester, Carol Thompson, Jennifer L. Wolff, Judith Hibbard & Robert A. Wise. (2018) Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease. JAMA 320:22, pages 2335.
Crossref
Crossref
Graham Devereux, Seonaidh Cotton, Shona Fielding, Nicola McMeekin, Peter J. Barnes, Andrew Briggs, Graham Burns, Rekha Chaudhuri, Henry Chrystyn, Lisa Davies, Anthony De Soyza, Simon Gompertz, John Haughney, Karen Innes, Joanna Kaniewska, Amanda Lee, Alyn Morice, John Norrie, Anita Sullivan, Andrew Wilson & David Price. (2018) Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD. JAMA 320:15, pages 1548.
Crossref
Crossref
Jaco Voorham, Nicolas Roche, Hicham Benhaddi, Marianka van der Tol, Victoria Carter, Job F.M. van Boven, Leif Bjermer, Marc Miravitlles & David B Price. (2018) Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. BMJ Open 8:10, pages e022051.
Crossref
Crossref
Harma Alma, Corina de Jong, Ioanna Tsiligianni, Robbert Sanderman, Janwillem Kocks & Thys van der Molen. (2018) Clinically relevant differences in COPD health status: systematic review and triangulation. European Respiratory Journal 52:3, pages 1800412.
Crossref
Crossref
Usman Maqsood, David JW Evans, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar & Iain Crossingham. (2018) Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Yuanbin Chen, Johannah Linda Shergis, Lei Wu, Xuhua Yu, Qigang Zeng, Yinji Xu, Xinfeng Guo, Anthony Lin Zhang, Charlie Changli Xue & Lin Lin. (2016) A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease. Complementary Therapies in Medicine 29, pages 94-108.
Crossref
Crossref
Sheila M Welsh, Andrea Sherriff & Gerd Flodgren. (2015) The champion for improved delivery of care to older people in long-term care settings: effects on professional practice, quality of care and resident outcomes. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Emma J Welsh, David J Evans, Stephen J Fowler & Sally Spencer. (2015) Interventions for bronchiectasis: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Michael Sarai, Don Sin, J. Mark FitzGerald & Shawn Aaron. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Paul W. Jones, Kai M. Beeh, Kenneth R. Chapman, Marc Decramer, Donald A. Mahler & Jadwiga A. Wedzicha. (2014) Minimal Clinically Important Differences in Pharmacological Trials. American Journal of Respiratory and Critical Care Medicine 189:3, pages 250-255.
Crossref
Crossref
David Price, Iain Small, John Haughney, Dermot Ryan, Kevin Gruffydd-Jones, Federico Lavorini, Tim Harris, Annie Burden, Jeremy Brockman, Christine King & Alberto Papi. (2013) Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients. Primary Care Respiratory Journal 22:4, pages 439-448.
Crossref
Crossref